Ampleia

Ampleia is a French company that builds innovative biotechnology companies focused on rare diseases by sourcing breakthrough research teams worldwide and delivering meaningful clinical results for patients and investors. The headquarters are located in France.

Here are key aspects of the company:

• Industries: Ampleia operates within the life sciences sector, specifically targeting the economics and unmet needs of rare diseases through a disciplined four-step approach to building impactful biotechs.
• Customers: The company serves patients requiring high clinical benefits for rare conditions and investors seeking higher success rates and investment multiples compared to common disease therapies.
• Innovation: Ampleia leverages a network of over 6,000 medical and scientific experts to advance programs with clinical rigor, identifying the best research teams and breakthrough innovation globally.
• Operations: The firm assembles execution-focused teams comprising operators, scientists, and investors to bring sourced programs to life, utilizing decades of combined experience in rare diseases from its leadership team.

Ampleia combines a proven track record in fighting rare diseases for over 65 years with a modern investment model designed to deliver superior financial returns alongside significant health outcomes.